Market Highlights

• ArsenalBio has raised $325.0 million in Series C funding to accelerate the development of its lead programs, which focus on therapeutic candidates for treating solid tumor cancers.
• Longfellow's ground lease in Emeryville for the 750,000-square-foot (sf) Atrium Labs development was terminated after allegations of $1,006,250 in unpaid rent.
• The UC Regents have approved the construction of UCSF’s new Life Sciences Building, which will feature a proton therapy center and a cutting-edge life sciences incubator. The facility is slated to open in 2029.

Read the full report